NCT00346190Unknown3 期
A Six Month Double-Blind, Placebo-Controlled Trial Followed by Six Month Open-Label Study of the Early Administration of Alendronate on Prevention of Bone Loss After Hip Fracture.
McGill University Health Centre/Research Institute of the McGill University Health Centre2 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2003年1月1日最近更新:
适应症
相关药物
试验速览
- 阶段
- 3 期
- 发起方
- 入组人数
- 10
- 试验地点
- 2
研究概览
简要总结
To determine whether administration of Alendronate early is more effective than late in the prevention of osteoporosis following a hip fracture
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Prevention
- 盲法
- Double
入排标准
- 年龄范围
- 55 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Male and Female aged > 55 Low trauma hip fracture up to 90 days Be willing to submit to periodic bone mineral density radiographic studies of the spine & 24 hr urine collection Written informed consent
排除标准
- •Disorders known to affect bone metabolism Not taking bisphosphonates within last 6 months Drugs known to interfere with calcium metabolism within the lats 6 months prior to hip fracture serum calcium> 2.65 mmol/L Treatment with any investigational drug within the last 30 days
研究者
研究点 (2)
Loading locations...
相似试验
已完成
2 期
Phase II randomized trial of alendronate to compare oral and intravenous administration for bone mineral density in gastrectomized patientsosteoporosis after gastrectomyJPRN-UMIN000013745Kanagawa Cancer Center60
已完成
4 期
A Study to Evaluate Alendronate Sodium /Vitamin D3 Combination Tablets(FOSAMAX PLUS) Versus Calcitriol in the Treatment of Osteoporosis in Postmenopausal Women in China (MK-0217A-264)Osteoporosis, PostmenopausalNCT01350934Organon and Co219
已完成
3 期
FLEX - Long-term Extension of FIT (Fracture Intervention Trial)(0217-051)Osteoporosis, PostmenopausalNCT00398931Organon and Co1,099
进行中（未招募）
1 期
En randomiseret kontrolleret undersøgelse af alendronat som forebyggende behandling mod udvikling af glucocorticoid induceret osteoporose hos patienter der behandles for malignt lymfom.Age = 18 years. Patients with new diagnosis or recurrence of lymphoma, which is expected to be treated with one of the listed chemotherapy regimens.Expected lifespan =2 yearsMedDRA version: 19.0Level: LLTClassification code 10025315Term: Lymphoma malignantSystem Organ Class: 100000004864EUCTR2015-005688-18-DKDepartment of Hematology, Aalborg University Hospital60
已完成
2 期
Safety and Efficacy of Alendronate (Fosamax) in Children With OsteoporosisOsteoporosisNCT00259857Medical University of South Carolina22